Dawn Svoronos - 07 Jan 2022 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
Director
Signature
/s/ Avraham S. Adler, attorney-in-fact
Issuer symbol
PTCT
Transactions as of
07 Jan 2022
Transactions value $
$-19,648
Form type
4
Filing time
11 Jan 2022, 15:14:30 UTC
Previous filing
21 Jun 2021
Next filing
18 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Sale $-19,648 -510 -1.88% $38.52 26,555 07 Jan 2022 Direct F1
transaction PTCT Common Stock Award $0 +3,200 +12.1% $0.000000 29,755 07 Jan 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTCT Stock Option (Right To Buy) Award $0 +12,000 $0.000000 12,000 07 Jan 2022 Common Stock 12,000 $38.10 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 963 RSUs from a January 6, 2021 grant of 1,650 RSUs.
F2 Restricted stock units granted on January 7, 2022 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 8, 2022 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 7, 2023.
F3 This option was granted on January 7, 2022 and vests over one year in twelve equal monthly installments, commencing on February 7, 2022.